PCR Technology Market to Reach $26.69B by 2030 at 9.9% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Biological Polymerase Chain Reaction (PCR) Technology Market Projected To Reach By 2030?
The market for biological polymerase chain reaction (pcr) technology has seen rapid expansion in recent years. This market is set to grow from $16.62 billion in 2025 to $18.31 billion in 2026, at a compound annual growth rate (CAGR) of 10.2%. The historical growth can be attributed to several factors, including the expansion of molecular diagnostics adoption, the increasing use of pcr in infectious disease testing, the growth of genomic research activities, a rising demand for accurate nucleic acid amplification, and improvements in thermal cycler technologies.
The market for biological polymerase chain reaction (pcr) technology is projected to experience substantial growth in the coming years. It is anticipated to expand to $26.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. The drivers behind this expansion during the forecast period include the increasing adoption of point-of-care pcr systems, the rising application of pcr in oncology and genetic testing, the broadening scope of personalized medicine, increased investments in laboratory automation, and a greater need for rapid diagnostic solutions. Furthermore, key trends expected during this period encompass the growing integration of real-time and digital pcr methodologies, an increasing requirement for high-sensitivity molecular diagnostics, the expanding incorporation of pcr data analysis software, a wider range of multiplex and high-throughput pcr applications, and a stronger emphasis on automating workflows.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Factors Are Driving The Biological Polymerase Chain Reaction (PCR) Technology Market Growth?
The anticipated expansion of the biological polymerase chain reaction (PCR) technology market is linked to an increase in infectious diseases. Infectious diseases are conditions or disorders arising from bacteria, viruses, fungi, or parasites. This rise in infectious disease incidence is driven by increasing global travel, which facilitates the faster and wider spread of pathogens across regions. Biological polymerase chain reaction (PCR) technology proves instrumental in combating these diseases through its capacity for swift and precise pathogen detection, which supports early diagnosis, prompt treatment, and efficient control of outbreaks. For example, in December 2024, data from the World Health Organization, a Switzerland-based intergovernmental agency, indicated that in 2023, malaria, a significant infectious disease, resulted in an estimated 263 million cases worldwide, an increase of roughly 252 million from 2022. The case incidence was 60.4 per 1,000 population at risk, rising from 58.6 in 2022, and there were 597,000 deaths, with 94 percent of cases and 95 percent of deaths concentrated in the WHO African Region. Consequently, the growing occurrence of infectious diseases is stimulating the expansion of the biological polymerase chain reaction (PCR) technology market.
How Is The Biological Polymerase Chain Reaction (PCR) Technology Market Broken Down By Segment Categories?
The biological polymerase chain reaction (pcr) technology market covered in this report is segmented –
1) By Product Type: Reagents, Consumables, Software And Services
2) By Technique: Real-Time Polymerase Chain Reaction (PCR), Conventional Polymerase Chain Reaction (PCR), Digital Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (PCR), Hot-Start Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR), Other Polymerase Chain Reaction (PCR) Techniques
3) By Application: Diagnostic Applications, Genotyping, Nucleic Acid Detection, Gene Expression Analysis, Nucleic Acid Synthesis, Genetic Sequencing, Environmental Applications, Standard Validation Or Verification, Other Applications
4) By End User: Hospital Laboratories, Diagnostic Laboratories, Academic And Government Organizations, Pharma-Biotech Companies, Other End Users
Subsegments:
1) By Reagents: DNA Polymerase, DNTPs, Primers And Probes, Buffers And Master Mixes, Enzymes, Nucleic Acid Templates, Additives And Enhancers
2) By Consumables: PCR Tubes, PCR Plates, Sealing Films And Mats, Microplates, Reaction Vessels, Pipette Tips, PCR Strips
3) By Software And Services: PCR Data Analysis Software, Real-Time PCR Analysis Software, Cloud-Based Data Storage Solutions, PCR Workflow Management Tools, Technical Support Services, Calibration And Maintenance Services, Training And Consultation Services
Which Trends Are Guiding The Direction Of The Biological Polymerase Chain Reaction (PCR) Technology Market?
Leading companies operating within the biological polymerase chain reaction (PCR) technology sector are prioritizing technological advancements, such as digital PCR assay kits, to facilitate precise and efficient quantification of DNA and RNA for biopharmaceutical research, cell and gene therapies, and food safety applications. Digital PCR assay kits are laboratory reagent kits utilized for highly sensitive and accurate DNA or RNA quantification through digital PCR technology. For instance, in November 2023, QIAGEN, a Netherlands-based provider of molecular biology solutions, introduced the QIAcuity Digital PCR Kits and an updated QIAcuity software, aiming to expand their utility in biopharma and food-safety testing. These kits leverage optimized reagents and consumables to divide nucleic acid samples into thousands of nanoliter-scale reactions, enabling sensitive detection and quantification of rare variants or pathogens. The refreshed software offers automated analysis, workflow guidance, and data visualization for simpler interpretation. Core features include high sensitivity, a wide dynamic range, multiplexing capability, and intuitive operation. Their applications encompass gene expression analysis, mutation detection, microbial testing, and quality control, providing enhanced accuracy, reduced manual time, and reliable low-copy detection across various research and regulatory contexts.
Which Players Are Present In The Biological Polymerase Chain Reaction (PCR) Technology Market Space?
Major companies operating in the biological polymerase chain reaction (pcr) technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Cepheid Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena GmbH+Co. KG, New England Biolabs Inc., Enzo Biochem Inc., LGC Biosearch Technologies Inc., Bioline Reagents Ltd., Illumina Inc., Abbott Laboratories
Get The Full Biological Polymerase Chain Reaction (PCR) Technology Market Report:
Which Region Accounts For The Largest Portion Of The Biological Polymerase Chain Reaction (PCR) Technology Market?
North America was the largest region in the biological polymerase chain reaction (PCR) technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological polymerase chain reaction (pcr) technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biological Polymerase Chain Reaction (PCR) Technology Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Biological Polymerase Chain Reaction (PCR) Technology Market 2026, By The Business Research Company
Food Hydrocolloids Market Report 2026
https://www.thebusinessresearchcompany.com/report/food-hydrocolloids-global-market-report
Hydrocolloids Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrocolloids-global-market-report
Hydrocortisone Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrocortisone-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
